ClinicalTrials.Veeva

Menu

Interest of Re-oxygenation After Inhalation of 50% Nitrous Oxide / 50% Oxygen Premix in Dental Cares

A

Air Liquide

Status and phase

Terminated
Phase 3

Conditions

Dental Cares Under Kalinox's Inhalation

Treatments

Drug: Air Médical
Drug: Oxygène

Study type

Interventional

Funder types

Industry

Identifiers

NCT00643786
EudraCT : 031003

Details and patient eligibility

About

The usefulness of re-oxygenation after inhalation of 50% nitrous oxide and 50% oxygen premix (Kalinox 170 bar) during dental care is studied and the pollution resulting from administration of Kalinox is also investigated.

Enrollment

128 patients

Sex

All

Ages

1+ year old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • From 1 year old
  • anxious or phobic patients
  • very young children requiring selective dental cares
  • mental deficient patients
  • ASA 1 or ASA 2 patients

Exclusion criteria

  • ASA 3 or ASA 4 patients
  • contraindication linked to the experimental product
  • patients with mental disorder incompatible with the motory test
  • patients that have received anxiolytic treatment less than 2 hours before the dental care

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

128 participants in 2 patient groups, including a placebo group

A
Experimental group
Description:
Oxygène
Treatment:
Drug: Oxygène
B
Placebo Comparator group
Description:
Air Médical
Treatment:
Drug: Air Médical

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems